Skip to main content
. 2021 Mar 22;10(6):1305. doi: 10.3390/jcm10061305

Table 4.

Feasibility and Safety results.

Complications after Treatment 13 Treatments with Fixed Geometry 12 Treatments with Variable Geometry
hyperpyrexia 7/13 (53.8%) 6/12 (50.0%)
Delayed gastric emptying without clinically significant signs 4/13 (30.8%) 3/12 (25.0%)
ascites 6/13 (46.1%) 2/12 (16.7%)
splenic infarction without thrombosis of the splenic vessels 3/13 (23.1%) 0/12 (0%)
pleural effusion 4/13 (30.8%) 2 (16.7%)